Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 8/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 7/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL435135 | 1.00 | CYP19A1 (0.37) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| Bromide SCHEMBL1179154 | 0.99 | CHRM3 (0.37) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| Bromide SCHEMBL1179151 | 0.99 | CHRM3 (0.37) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL523915 | 0.95 | CYP19A1 (0.34) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL1181165 | 0.95 | CYP19A1 (0.34) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL523914 | 0.94 | CYP19A1 (0.34) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL1109891 | 0.94 | CHRM2 (0.37) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| SCHEMBL1109893 | 0.94 | CHRM2 (0.37) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| Bromide SCHEMBL2877682 | 0.93 | CHRM2 (0.36) | CYP19A1CHRM3CHRM2CHRM1KCNH2 | |
| Bromide SCHEMBL2877676 | 0.93 | CHRM2 (0.36) | CYP19A1CHRM3CHRM2CHRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2448623-B1 | DISPENSER AND METHOD FOR ENTRAINING POWDER IN AN AIRFLOW | ASTRAZENECA AB (SE) | 2017-12-20 | — | — | EP | claimed |
| EP-2341968-B1 | A BREATH ACTIVATED INHALER | ASTRAZENECA AB (SE) | 2017-05-10 | — | — | EP | claimed |
| US-9289565-B2 | Inhaler with indexing linked to movement of cover | ASTRAZENECA AB (SE) | 2016-03-22 | — | — | US | claimed |
| EP-2334358-B1 | INHALATION DEVICE FOR DISPENSING MEDICAMENT | ASTRAZENECA AB (SE) | 2016-02-10 | — | — | EP | claimed |
| US-9155851-B2 | Breath activated inhaler | ASTRAZENECA AB (SE) | 2015-10-13 | — | — | US | claimed |
| US-9095670-B2 | Inhalation device and method of dispensing medicament | ASTRAZENECA AB (SE) | 2015-08-04 | — | — | US | claimed |
| EP-2595683-B1 | Inhaler | ASTRAZENECA AB (SE) | 2015-03-04 | — | — | EP | claimed |
| US-20140083422-A1 | INHALER | ASTRAZENECA AB | 2014-03-27 | — | — | US | claimed |
| US-8578933-B2 | Entraining powder in an airflow | ASTRAZENECA AB (SE) | 2013-11-12 | — | — | US | claimed |
| CN-102245239-B | Inhalation device and method of dispensing a medicament | ASTRAZENECA AB | 2013-08-14 | — | — | CN | claimed |
| EP-2124941-A1 | COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST | Argenta Discovery Limited (GB) | 2009-12-02 | — | — | EP | claimed |
| EP-2125728-A1 | NOVEL COMBINATION OF COMPOUNDS TO BE USED IN THE TREATMENT OF AIRWAY DISEASES, ESPECIALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA | AstraZeneca AB (SE) | 2009-12-02 | — | — | EP | claimed |
| EP-2118078-A2 | NEW SALT | Argenta Discovery Ltd (GB) | 2009-11-18 | — | — | EP | claimed |
| CN-101282949-A | Azole and thiazole derivatives and their use | ARGENTA DISCOVERY LTD (GB) | 2008-10-08 | — | — | CN | claimed |
| WO-2008103125-A1 | NOVEL COMBINATION OF COMPOUNDS TO BE USED IN THE TREATMENT OF AIRWAY DISEASES, ESPECIALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA | ASTRAZENECA AB (SE) | 2008-08-28 | — | — | WO | claimed |
| WO-2008096126-A1 | COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST | ARGENTA DISCOVERY LTD (GB) | 2008-08-14 | — | — | WO | claimed |
| WO-2008096136-A1 | COMBINATIONS WITH A MUSCARINIC RECEPTOR ANTAGONIST | ARGENTA DISCOVERY LTD (GB) | 2008-08-14 | — | — | WO | claimed |
| WO-2008096149-A2 | NAPADISYLATE SALT OF A MUSCARINIC M3 ANTAGONIST | ARGENTA DISCOVERY LTD (GB) | 2008-08-14 | — | — | WO | claimed |
| EP-1924570-A1 | AZOLE AND THIAZOLE DERIVATIVES AND THEIR USE | Argenta Discovery Limited (GB) | 2008-05-28 | — | — | EP | claimed |
| WO-2007017669-A1 | AZOLE AND THIAZOLE DERIVATIVES AND THEIR USE | ARGENTA DISCOVERY LTD. (GB) | 2007-02-15 | — | — | WO | claimed |